Solmaz S et al. |
Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant. |
2017 |
Exp Clin Transplant |
pmid:26643544
|
Charman C |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment. |
2017 |
Br. J. Dermatol. |
pmid:28858382
|
Zaza G et al. |
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. |
2017 |
PLoS ONE |
pmid:28542523
|
Kanate AS et al. |
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28412518
|
Ito A et al. |
Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3. |
2017 |
Biochem. Genet. |
pmid:28324194
|
Ayar Y et al. |
Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience. |
2017 |
Transplant. Proc. |
pmid:28219583
|
Keller F et al. |
Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients
. |
2017 |
Clin. Nephrol. |
pmid:28025957
|
Ren L et al. |
Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients. |
2017 |
Pharmacogenomics |
pmid:28084894
|
Li R et al. |
Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis. |
2017 |
Photodermatol Photoimmunol Photomed |
pmid:27696531
|
Dabrowska-Zamojcin E et al. |
KCNJ11 and KCNQ1 Gene Polymorphisms Are Not Associated with Post-Transplant Diabetes Mellitus in Kidney Allograft Recipients Treated with Tacrolimus. |
2017 |
Folia Biol. (Praha) |
pmid:28805561
|